Conflict of interest in the debate over calcium-channel antagonists.
Opie
L
L
D001319:Authorship; D002121:Calcium Channel Blockers / Q000009:adverse effects* / Q000145:classification; D016265:Conflict of Interest; D004345:Drug Industry / Q000191:economics; D006801:Humans; D012108:Research Personnel / Q000191:economics; D012109:Research Support as Topic
D002121:Calcium Channel Blockers